MAY 15, 2018 11:33 PM PDT

Genomic Surgery to Treat Eye Disease

WRITTEN BY: Carmen Leitch

CRISPR is a powerful technique that can make permanent edits to the genome, and scientists are trying to perfect it for use in the clinic to treat patients. Errors in the genetic code can cause serious diseases, which might be repaired instead of trying to ease symptoms. Now researchers have used CRISPR to treat damage in mice that model retinitis pigmentosa, a degenerative disorder of the eye, by repairing the genetic mutation. The method, which replaced a dysfunctional gene with a normal one, has been reported in the journal Ophthalmology.

Image credit: Pixabay

CRISPR can act as a kind of scissor that cuts the genome, and because cells will act to repair such cuts, a template containing the correct gene can be added to cells along with the CRISPR reagents. The cell machinery can then use the right gene as a template when it fixes the cut portion of the genome. Researcher Stephen H. Tsang, M.D., Ph.D., and his colleagues think of the method as a kind of genomic surgery. Tsang believes they will be able to test their technique on patients within three years.

"Genome surgery is coming," said Dr. Tsang. "Ophthalmology will be the first to see genome surgery before the rest of medicine."

In people with retinitis pigmentosa, cells in their retinas breakdown and are lost. The disease affects about one of 4,000 people. Usually beginning in childhood, night and peripheral vision are impacted at first. As it progresses into adulthood, it will usually cause blindness in patients by the time they turn 40.

In the autosomal dominant form of the disorder, a person inherits one bad copy of the rhodopsin gene from one parent and usually gets a good copy from the other parent. That means that a treatment must selectively target the bad copy. In autosomal recessive cases, two bad copies, one from each parent, have to be inherited to cause the disease.

Tsang’s team focused on correcting the detrimental copy in a strategy to ‘ablate and replace’ which can fix any number of different mutations, instead of focusing on only one. Over 150 different rhodopsin gene mutations can cause the disease, making this tool especially useful.

 While the CRISPR tool usually targets one small region of the genome, the team’s design targeted two areas of the rhodopsin gene instead. That increased their ability to disrupt it, from 30 to 90 percent. A viral vector was used to deliver the good replacement copy of the gene to the retina for incorporation into the cells there.

The researchers were also able to use their method to correct sequences in cells that were not dividing, an important feature for therapeutic use.

After testing it on their mouse model, the scientists found that the retinal function improved, and degeneration of the retina was slowed.

The video above from Nature describes and animates some of the many different techniques that are made possible by CRISPR.


Sources: AAAS/Eurekalert! Via American Academy of Ophthalmology, Ophthalmology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 03, 2018
Genetics & Genomics
JUL 03, 2018
Sequencing of Koala Genome Provides Insight Into the Unique Species
Koalas are fascinating animals, and their populations have proven difficult to manage. New work will change that....
JUL 23, 2018
JUL 23, 2018
Anglerfish Alert Researchers to a Third Type of Symbiosis
The light from inside the anglerfish bulb is made by bioluminescent bacteria, a symbiotic relationship we know little about....
AUG 13, 2018
Genetics & Genomics
AUG 13, 2018
Heritable and Environmental Factors Influence Gene Activity
Even if something gets described as epigenetic, it does not necessarily mean it's an environmental effect....
AUG 14, 2018
AUG 14, 2018
What is Leigh Syndrome?
While neurological conditions such as Alzheimer's disease, ALS, Parkinson's and glioblastomas are frequently studied, other disorders are not as we...
SEP 04, 2018
Drug Discovery
SEP 04, 2018
Cellular Mechanism Inspires Bone-Forming Drugs
There exists a certain amount of therapeutic drugs that treat osteoporosis by promoting bone formation in comparison to only a few drugs used to suppress b...
SEP 17, 2018
Cell & Molecular Biology
SEP 17, 2018
A Fast New Method to Make an Important Type of Brain Cell
Scientists have developed a better way to create astrocytes, a cell type hat has been implicated in neurodegenerative diseases....
Loading Comments...